p53 overexpression in small hepatocellular carcinomas containing two different histologic grades

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 455-459

  Nakashima, Yutaka ^a   Hsia, Chu Chieh ^a   Yuwen, Hao ^a   Minemura, Masami ^a   Nakashima, Osamu ^b   Kojiro, Masamichi ^b   Tabor, Edward ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocellular carcinoma; p53 gene

Indexed keywords

CLENBUTEROL;

ADULT; AGED; ARTICLE; CANCER GRADING; FEMALE; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 13144250127     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.455     Document Type: Article

References (24)

1. Kenmochi K, Sugihara S and Kojiro M: Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC [sic]. Liver 7: 18-26, 1987.
2. Kojiro M, Sugihara S and Nakashima O: Pathomorphologic characteristics of early hepatocellular carcinoma. Gann Monograph Cancer Res 38: 29-37, 1991.
3. Sakamoto M, Hirohashi S and Shimosato Y: Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 22: 172-178, 1991.
4. Nigro JM, Baker SJ, Prcisinger AC, Milburn Jessup J, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weston A, Modali R, Harris CC and Vogelstein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708, 1989.
5. Murakami Y, Hayashi K, Hirohashi S and Sekiya T: Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res 51: 5520-5525, 1991.
6. Teramoto T, Satonaka K, Kitazawa S, Fujimori T, Hayashi K and Maeda S: p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis. Cancer Res 54: 231-235, 1994.
7. Liver Cancer Study Group of Japan: The general rules for the clinical and pathological study of primary liver cancer. Kanehara Shuppan, Tokyo, pp32-69, 1992.
8. Vojtesek B, Bártek J, Midgley CA and Lane DP: An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 151: 237-244, 1992.
9. Rodrigues NR, Rowan A, Smith MEF, Kerr IB, Bodmer WF, Gannon JV and Lane DP: p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 87: 7555-7559, 1990.
10. Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ and Harris CC: Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350: 427-428, 1991.
11. Bressac B, Kew M, Wands J and Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350:429-431, 1991.
12. Challen C, Lunec J, Warren W, Collier J and Bassendine MF: Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain. Hepatology 16: 1362-1366, 1992.
13. Sheu J-C, Huang G-T, Lee P-H, Chung J-C, Chou H-C, Lai M-Y, Wang J-T, Lee H-S, Shih L-N, Yang P-M, Wang T-H and Chen D-S: Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res 52: 6098-6100, 1992.
14. Oda T, Tsuda H, Scarpa A, Sakamoto M and Hirohashi S: p53 gene mutation spectrum in hepatocellular carcinoma. Cancer Res 52: 6358-6364, 1992.
15. Baker SJ, Preisinger AC, Milburn Jessup J, Paraskcva C, Markowitz S, Wilson JKV, Hamilton S and Vogelstein B: p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 50:7717-7722, 1990.
16. Ito T, Seyama T, Mizuno T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N and Akiyama M: Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Res 52: 1369-1371, 1992.
17. Sidransky D, Mikklesen T, Schwechheimer K, Rosenblum ML, Cavenee W and Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355: 846-847, 1992.
18. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD and Seizinger BR: p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 52: 2987-2990, 1992.
19. Tabor E: Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J Med Virol 42: 357-365, 1994.
20. Tanaka S, Toh Y, Adachi E, Matsumata T, Mori R and Sugimachi K: Tumor progression in hepatocellular carcinoma may be mediated by p53 mulation. Cancer Res 53: 2884-2887, 1993.
21. Bennett WP, Hollstein MC, He A, Zhu SM, Resau JH, Trump BF, Metcalf RA, Welsh JA, Midgley C, Lane DP and Harris CC: Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 6: 1779-1784, 1991.
22. Ng IOL, Srivastava G, Chung LP, Tsang SWY and Ng MMT: Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people. Cancer 74: 30-37, 1994.
23. Volkmann M, Hofmann WJ, Müller M, Räth U, Otto G, Zentgraf H and Galle PR: p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation. Oncogene 9: 195-204, 1994.
24. Oda T, Tsuda H, Sakamoto M and Hirohashi S: Different mutations of the p53 gene in nodule-in-nodule hepatocellular carcinoma as a [sic] evidence for multistage progression. Cancer Lett 83: 197-200, 1994.